Challenges in the evaluation of HER2 and HER2-low in breast cancer in Brazil and recommendations of a multidisciplinary working group

Rev Assoc Med Bras (1992). 2024 Sep 30;70(10):e20240313. doi: 10.1590/1806-9282.20240313. eCollection 2024.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Brazil
  • Breast Neoplasms* / genetics
  • Female
  • Humans
  • Practice Guidelines as Topic
  • Receptor, ErbB-2* / analysis

Substances

  • Receptor, ErbB-2
  • ERBB2 protein, human